Literature DB >> 12542556

Prevalence and significance of cardiovascular risk factors in a large cohort of patients with familial hypercholesterolaemia.

P R W de Sauvage Nolting1, J C Defesche, R J A Buirma, B A Hutten, P J Lansberg, J J P Kastelein.   

Abstract

OBJECTIVE: Patients with familial hypercholesterolaemia (FH) vary widely in terms of onset of cardiovascular disease (CVD).
DESIGN: The association between cardiovascular risk factors and prevalent CVD was examined in a cross-sectional study in order to elucidate their contribution to atherogenesis. SETTING AND
SUBJECTS: Patients were recruited from 37 Dutch Lipid Clinics. The diagnosis of FH was based on a uniform diagnostic protocol, confirmed by DNA analysis in 62% of the cases. All patients were investigated free from any lipid-lowering drug for at least 6 weeks. MAIN OUTCOME MEASURES: Differences in lipids, lipoproteins and other risk factors for CVD were analysed in FH patients with and without CVD.
RESULTS: A total of 526 patients were assessed and more than 37% had a history of CVD with a mean age of onset of 46.8 years. Mean LDL cholesterol (LDL-C) levels were severely elevated (8.38 +/- 2.13 mmol L-1). In univariate analysis, age, presence of hypertension or diabetes, body mass index, triglycerides (TG) and low HDL cholesterol (HDL-C) were all significantly associated with CVD. Also in multivariate analysis, all these risk factors, except TG and diabetes, were significantly linked to CVD.
CONCLUSION: A high CVD risk in this large well-documented characterized sample of FH patients is not only conferred by elevated LDL-C but also by low HDL-C.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12542556     DOI: 10.1046/j.1365-2796.2003.01070.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  12 in total

1.  Familial hypercholesterolemia associated with severe hypoalphalipoproteinemia in a Moroccan family.

Authors:  Karima Ait Chihab; Rachif Chater; Ana Cenarro; Anass Kettani; Sergio Castillo; Mohamed Loutfi; Josep Ribalta; Ahmed Adlouni; Miguel Pocovi; Mariame El Messal
Journal:  J Genet       Date:  2007-08       Impact factor: 1.166

Review 2.  My Approach to the Patient With Familial Hypercholesterolemia.

Authors:  Maya S Safarova; Iftikhar J Kullo
Journal:  Mayo Clin Proc       Date:  2016-06       Impact factor: 7.616

Review 3.  Familial Hypercholesterolaemia in the Era of Genetic Testing.

Authors:  D P Hughes; A Viljoen; A S Wierzbicki
Journal:  Curr Cardiol Rep       Date:  2016-05       Impact factor: 2.931

4.  Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia.

Authors:  H A W Neil; V Seagroatt; D J Betteridge; M P Cooper; P N Durrington; J P Miller; M Seed; R P Naoumova; G R Thompson; R Huxley; S E Humphries
Journal:  Heart       Date:  2004-12       Impact factor: 5.994

5.  Dietary resveratrol increases the expression of hepatic 7α-hydroxylase and ameliorates hypercholesterolemia in high-fat fed C57BL/6J mice.

Authors:  Qiong Chen; Ermao Wang; Liping Ma; Pei Zhai
Journal:  Lipids Health Dis       Date:  2012-05-20       Impact factor: 3.876

6.  R353Q polymorphism in the factor VII gene and cardiovascular risk in Heterozygous Familial Hypercholesterolemia: a case-control study.

Authors:  Juan Criado-García; Francisco Fuentes; Cristina Cruz-Teno; Antonio García-Rios; Anabel Jiménez-Morales; Javier Delgado-Lista; Pedro Mata; Rodrigo Alonso; José López-Miranda; Francisco Pérez-Jiménez
Journal:  Lipids Health Dis       Date:  2011-04-09       Impact factor: 3.876

7.  Risk stratification of patients with familial hypercholesterolemia in a multi-ethnic cohort.

Authors:  Matthew D Allard; Ramesh Saeedi; Masoud Yousefi; Jiri Frohlich
Journal:  Lipids Health Dis       Date:  2014-04-08       Impact factor: 3.876

Review 8.  Systematic review of published Phase 3 data on anti-PCSK9 monoclonal antibodies in patients with hypercholesterolaemia.

Authors:  Ioanna Gouni-Berthold; Olivier S Descamps; Uwe Fraass; Elizabeth Hartfield; Kim Allcott; Ricardo Dent; Winfried März
Journal:  Br J Clin Pharmacol       Date:  2016-10-04       Impact factor: 4.335

9.  Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk.

Authors:  S E Humphries; R A Whittall; C S Hubbart; S Maplebeck; J A Cooper; A K Soutar; R Naoumova; G R Thompson; M Seed; P N Durrington; J P Miller; D J B Betteridge; H A W Neil
Journal:  J Med Genet       Date:  2006-12       Impact factor: 6.318

10.  An enquiry based on a standardised questionnaire into knowledge, awareness and preferences concerning the care of familial hypercholesterolaemia among primary care physicians in the Asia-Pacific region: the "Ten Countries Study".

Authors:  Jing Pang; Miao Hu; Jie Lin; Takashi Miida; Hapizah M Nawawi; Jeong Euy Park; Xue Wu; Anis S Ramli; Ngoc Thanh Kim; See Kwok; Lourdes E Gonzalez-Santos; Ta-Chen Su; Thanh Huong Truong; Handrean Soran; Shizuya Yamashita; Brian Tomlinson; Gerald F Watts
Journal:  BMJ Open       Date:  2017-10-25       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.